Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2004
10/20/2004CN1171589C Urease inhibitors
10/20/2004CN1171588C Application of ivermectin for preparing medicine for treatment of seborrhea
10/20/2004CN1171587C Gamma-contained aminobutyric acid derivatives solid compositions and preparation process thereof
10/20/2004CN1171586C Pharmaceutical compositions comprising monoamine oxidase B inhibitors
10/20/2004CN1171585C Pharmaceutical preparations containing dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease
10/20/2004CN1171584C Process for enhancing immune response in animals using 'beta'-carotene as dietary supplement
10/20/2004CN1171583C Medical percutaneous preparation containing hydrophilic or salt form
10/20/2004CN1171582C Oral pharmaceutical extended release dosage form
10/20/2004CN1171580C Anhydrous antiperspirant cream compositions having improved perfume longevity
10/20/2004CN1171579C Foaming compsn. for hair care
10/19/2004USRE38629 Bioavailability; non-insulin depedent diabetes; hypoglycemic agents; treating metabolic disorders, impaired glucose tolerance, and insulin resistance
10/19/2004USRE38628 Pharmaceutical compositions
10/19/2004US6806376 Method for the preparation of citalopram
10/19/2004US6806373 Dissolving leflunomide in a solvent to form a leflunomide solution, crystallizing leflunomide form iii from the leflunomide solution, and isolating leflunomide form iii, useful for the treatment of rheumatoid arthritis
10/19/2004US6806370 NK-1 receptor active amine oxide prodrugs
10/19/2004US6806369 N-formyl-n-hydroxy-2-(5-isoquinolinoxy)ethylamine anti-bacterial compounds
10/19/2004US6806364 Ophthalmic compositions
10/19/2004US6806312 Thermoplastic resin composition
10/19/2004US6806294 Formulated for sustained (rapid or delayed) release of tramadol (hydrochloride); uniformity
10/19/2004US6806293 Sreening for mitogen activated protein (map) interaction
10/19/2004US6806290 Lovastatin, pravastatin, simvastatin, mevastatin, atorvastatin, and derivatives and analogs thereof are known as hmg-coa reductase inhibitors and are used as antihypercholesterolemic agents. the majority of them are
10/19/2004US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects
10/19/2004US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/19/2004US6806284 Reduces level of necessary systemic dose and side effects; promotes drug excretion; bacteriopheophorbide or pheophorbide with glucosamine moieties
10/19/2004US6806282 Branched substituted amino derivatives of 3-amino-1-phenyl-1h-[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
10/19/2004US6806281 Treatment of cocaine abuse, parkinson's disease
10/19/2004US6806280 Polymorph of 5-[4-[2-(n-methyl-n(2-pyridyl)amino)ethoxy]benzyl]-thiazolidine-2,4-dione, maleic acid salt
10/19/2004US6806278 Amino-tetralin derivatives as muscarinic receptor antagonists
10/19/2004US6806274 Quinazoline derivatives
10/19/2004US6806273 Compounds
10/19/2004US6806268 Method for treating glaucoma V
10/19/2004US6806267 Apoptosis-inducing compounds
10/19/2004US6806266 Staurosporin derivatives
10/19/2004US6806265 For therapy and prophylaxis of hiv infection
10/19/2004US6806263 New 17 alpha -fluoroalkyl steroids of general formula i as antiestrogens
10/19/2004US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
10/19/2004US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent
10/19/2004US6806259 Low molecular weight hyaluronic acid for use as a nutritional supplement to cause softening of human skin.
10/19/2004US6806257 Using such as oroxylin a and/or wogonin; septic shock, aneurysm, angiotensin converting enzyme inhibition; antiinflammatories
10/19/2004US6806256 Especially a bitter tasting antibiotic containing an artificial sweetener
10/19/2004US6806253 Therapeutic and preventive anti-bacterial vaccine complex
10/19/2004US6806252 Synergistic mixture of casein polypeptide to promote calcium absorption and genistein which inhibits bone resorption and promotes osteogenesis; prevent decrease in bone density and onset of osteoporosis
10/19/2004US6806243 Ophthalmic solution and contact lens solution
10/19/2004US6806069 Ubiquinone composition and methods related thereto
10/19/2004US6805883 Contain cocoa and/or nut procyanidin(s)
10/19/2004US6805881 Orally administrable multiple- unit sustained-release dosage forms having controlled agitation- independent release of active compound; erodable hydroxypropyl cellulose
10/19/2004US6805880 Pharmaceutical delivery system for vitamin C and vitamin E and use of a combination of vitamin C and E for preventing or treating conditions involving oxidative stress
10/19/2004US6805878 Transdermal administration of ACE inhibitors
10/19/2004US6805873 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
10/19/2004US6805863 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
10/19/2004US6805861 Administering therapeutically effective amount of cytotoxic t lymphocytes which have different hla class i complex (or equivalent) than cells to be killed, and specifically recognize peptide portion of antigen presented on cell surface
10/19/2004US6805857 Method of modulating factor D, factor H and CD4 cell immune response with a polystyrene sulfonate, alginate, and saline infusion solution
10/19/2004US6805855 Cool and dry antiperspirant stick
10/19/2004US6805854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route
10/19/2004US6805853 Delivery of diazepam through an inhalation route
10/19/2004CA2343336C Processes for preparing intermediates to nizatidine
10/19/2004CA2338070C Diltiazem controlled release formulation and method of manufacture
10/19/2004CA2308783C Novel derivatives of 1-aza-2-alkyl-6-aryl-cycloalkanes, process for their preparation and pharmaceutical compositions containing them
10/19/2004CA2296901C Piperidine derivates having anxiolytic effect
10/19/2004CA2238574C Targeted cytotoxic anthracycline analogs
10/19/2004CA2155796C 2,3-dihydro-1h-isoindole derivatives, a process for their preparation and their use as serotonin reuptake inhibitors
10/19/2004CA2143210C Functional radar warning receiver back-up generator
10/19/2004CA2139929C Transdermal therapeutic system containing the active substance 17-.beta.-oestradiol (anhydrous)
10/19/2004CA2113404C 17,20-epoxide derivatives of pregnane, their preparation and their application to the preparation of cortisone derivatives and intermediates
10/19/2004CA1341460C Production and use of porphyrin derivatives and of compositions containing such derivates
10/15/2004CA2464501A1 Treatment of lipodystrophy (lipid redistribution syndrome)
10/14/2004WO2004088276A2 A method and kit for detecting the early onset of renal tubular cell injury
10/14/2004WO2004087893A1 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
10/14/2004WO2004087880A2 Compounds and their use to treat diabetes and related disorders
10/14/2004WO2004087877A2 Selected rna motifs to include cell death and/or apoptosis
10/14/2004WO2004087862A2 Tak1-mediated inhibition of osteogenesis
10/14/2004WO2004087740A2 Preserved and stable compositions containing peptide copper complexes and methods related thereto
10/14/2004WO2004087729A1 Degradation products of azithromycin, and methods for their identification
10/14/2004WO2004087727A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
10/14/2004WO2004087721A1 Camphanylidene and phenylalkyl inositol polyphosphate compounds, compositions, and methods of their use
10/14/2004WO2004087717A1 Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines as potential antitumour agents and process thereof
10/14/2004WO2004087716A1 Pyrrolo[(2,1-c)(1,4) benzodiazepines dimers as antitumour agents and process thereof
10/14/2004WO2004087714A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004WO2004087713A1 Salts of tricyclic inhibitors of poly(adp-ribose) polymerases
10/14/2004WO2004087711A1 Pyrene-linked pyrrolo (2,1-c) (1,4) benzodiazepine derivatives useful as anticancer agents
10/14/2004WO2004087710A1 Pyrrolo`1,2-b!pyridazine compounds and their use as crf1 receptor antagonists
10/14/2004WO2004087709A1 Pyrrolo[1,2-b]pyridazine compounds and their uses
10/14/2004WO2004087708A1 Pyrrolo (1,2-b) pyridazine compounds and their use as cfr-1 receptor antagonists
10/14/2004WO2004087707A1 Pyrazolopyrimidine compounds and their use in medicine
10/14/2004WO2004087704A1 Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
10/14/2004WO2004087701A1 Cyclic benzimidazoles
10/14/2004WO2004087699A2 Thiazoles useful as inhibitors of protein kinases
10/14/2004WO2004087698A2 Thiazoles useful as inhibitors of protein kinases
10/14/2004WO2004087696A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
10/14/2004WO2004087695A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
10/14/2004WO2004087693A1 Oxime derivatives and their use as pharmaceutically active agents
10/14/2004WO2004087688A1 Novel crystalline forms of gatifloxacin
10/14/2004WO2004087687A1 Chromene derivatives as anti-inflammatory agents
10/14/2004WO2004087686A2 Benzopyran compounds useful for treating inflammatory conditions
10/14/2004WO2004087679A1 2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases
10/14/2004WO2004087673A2 Migrastatin analogs and uses thereof
10/14/2004WO2004087672A1 Migrastatin analog compositions and uses thereof
10/14/2004WO2004087669A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
10/14/2004WO2004087662A1 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
10/14/2004WO2004087659A1 Chemical compounds
1 ... 4922 4923 4924 4925 4926 4927 4928 4929 4930 4931 4932 4933 4934 4935 4936 4937 4938 4939 4940 4941 4942 ... 7860